PNW
60
-4
RIG
43
-7
HAL
55
-5
PEG
50
-3
PLD
48
-2
NTRS
64
-3
BAX
50
2
HRB
41
3
GOOG
73
14
EMR
65
-8
HPE
64
-5
DTE
38
-2
AMAT
49
-6
PNR
66
-2
AME
65
-6
RSG
51
3
SO
44
-4
CHD
37
2
EXPD
37
-5
TEL
74
-14
PNW
60
-4
RIG
43
-7
HAL
55
-5
PEG
50
-3
PLD
48
-2
NTRS
64
-3
BAX
50
2
HRB
41
3
GOOG
73
14
EMR
65
-8
HPE
64
-5
DTE
38
-2
AMAT
49
-6
PNR
66
-2
AME
65
-6
RSG
51
3
SO
44
-4
CHD
37
2
EXPD
37
-5
TEL
74
-14
Financhill
Back

Apellis Pharmaceuticals, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
56

APLS
Apellis Pharmaceuticals, Inc.

Last Price:
$25.23
Seasonality Move:
7.92%
Sell
39

MNPR
Monopar Therapeutics, Inc.

Last Price:
$74.46
Seasonality Move:
36.18%
Buy
56
Apellis Pharmaceuticals, Inc. (APLS) is a Buy

Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals, Inc. [APLS] share price is $25.23. The Score for APLS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $74.61. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals, Inc.'s stock price today?

  • The Apellis Pharmaceuticals, Inc. share price today is $25.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $74.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.69 Buy
Relative Strength Index (14 RSI): 68.46 Buy
Chaikin Money Flow: 1409326 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.36 - 23.18) Buy
Bollinger Bands (100): (20.82 - 26.96) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.71 Sell
Relative Strength Index (14 RSI): 41.23 Sell
Chaikin Money Flow: -100149 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.75 - 86.63) Sell
Bollinger Bands (100): (43.73 - 88.49) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.69 Buy
20-day SMA: 21.71 Buy
50-day SMA: 23.11 Buy
200-day SMA: 21.92 Buy
8-day EMA: 23.84 Buy
20-day EMA: 22.66 Buy
50-day EMA: 22.73 Buy
200-day EMA: 24.25 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.35 Sell
20-day SMA: 81.26 Sell
50-day SMA: 84.43 Sell
200-day SMA: 51.38 Buy
8-day EMA: 77.66 Sell
20-day EMA: 80.1 Sell
50-day EMA: 78.38 Sell
200-day EMA: 56.01 Buy

Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Apellis Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):